Type 1 Diabetes MellitusNCT06599840
Feasibility Study of a Behavioral Parent Intervention to Support Self-management in Pediatric Typ 1 Diabetes
A study testing Parent intervention in people with Type 1 Diabetes Mellitus and Parent-Child Relations, run by Karolinska Institutet at 1 site in Sweden.
Trial summary
This study investigates feasibility and preliminary effects of a new behavioral parent intervention that aims to support and improve pediatric diabetes self-management Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Type 1 Diabetes Mellitus, Parent-Child Relations, Self-management
- What is being tested?
- Parent intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 17 participants
- Where
- 1 siteSweden
- Study dates
- 20 Sep 2024to 1 Nov 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Parents/guardians of children aged 9-14 with type 1 diabetes.
- The child has had type 1 diabetes for at least one year.
- The parent experience difficulties in managing daily life and/or the parent-child collaboration around self-management routines.
- The perceived difficulties should not solely be due to perceived problems in the medical aspects of the diabetes treatment, such as a perceived need for more support in insulin dosing, more diabetes education, or technical/medical support. This criterion is based solely on the subjective judgement of the parent him-/herself.
- The child receives diabetes care at one of the three diabetes clinics in the Stockholm Region.
- The parent speaks, understands, and can read Swedish.
- The parent claims to be motivated and has the practical possibility to participate in the study and attend group meetings.
Who cannot join
- The parent reports current and severe psychiatric conditions in themselves or the child that need to be prioritized, such as severe depression, suicidal thoughts/self-harm, psychosis, or mania.
- The parent is involved in another psychological treatment of a behavior-changing nature that is in an active phase, either concerning themselves or a child.
- Major planned changes in diabetes treatment that require learning and behavioral changes, such as transitioning from pen to pump, and that are expected to occur during the first 3.5 months of the study (active intervention phase).
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Improving Self-management in Childhood Diabetes - Feasibility and Preliminary Effects of a CBT-based Intervention for Parents
This study investigates feasibility and preliminary effects of a new behavioral parent intervention that aims to support and improve pediatric diabetes self-management
Read the detailed description
Diabetes self-management is extensive, complex and places high demands on the affected individual and his/her family. Today, half of Swedish children and adolescents with type 1 diabetes (T1D) do not reach target levels of glycemic control. Among the various factors that influence glycemic control, family function is of great importance. Parent-child conflicts surrounding self-management tasks have been shown to predict glycemic control deterioration over time. This study will explore feasibility and preliminary effects of a new behavioral parent intervention that aims to strengthen parent-child cooperation and facilitate diabetes routines in every-day-life. The results of the feasibility study will guide further refinement of the intervention, and the design of a future RCT.
Through digital ads and posters at the diabetes clinics in Stockholm, we will recruit parents of children aged 9-14 with T1D experiencing problems in getting diabetes self-management routines to work in every-day-life. The intervention is held at the hospital and includes six weekly group sessions and a booster session one month later. At the end of each session, parents plan to use a new behavioral strategy at home during the upcoming week. This feasibility study will explore participant satisfaction and attendance combined with qualitative assessments of their experiences. Preliminary effects are investigated through repeated assessments of a set of digitalized questionnaires, data from the national diabetes registry and online blood glucose data during the intervention phase, post intervention and at 3- months follow up.
This intervention is believed to be an effective way to target and prevent T1D self-management problems and may come to serve as an important complement to standard diabetes treatment.
- Conditions
- Type 1 Diabetes Mellitus, Parent-Child Relations, Self-management, Behavioral Intervention
- Being tested
- Parent intervention
- Keywords
- feasibility study, type 1 diabetes, diabetes self-management, parent support, parent intervention, pediatric self-management, behavioral intervention, pediatric type 1 diabetes, self-management problems, parent training, CBT, T1D, self-management intervention
- Medical subject headings
- Diabetes Mellitus, Type 1
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Parent interventionBehavioural
This is a novel intervention based on established CBT-based parenting strategies that are regularly used to strengthen parent-child cooperation and reduce conflicts. Here, the strategies are adapted to address typical challenges of T1D family life. The program structure consists of six weekly modules and a seventh booster module. Each of the first six modules has a theme with information on a parental strategy associated with the theme, self-reflective questions, and an assignment where parents plan to implement the strategy during the upcoming week. One month later, a seventh session is held to summarize the program and make plans for future progress.
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Other | CBT-based parent intervention consisting of 7 group sessions. Receives: Behavioral: Parent intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Diabetes Treatment Satisfaction Questionnaire - parent report
This is a 14 item questionnaire that aim to measure parental satisfaction with the diabetes treatment. Parents are asked to rate their satisfaction on a likert scale from 0 = very unsatisfied, to 6 = very satisfied about a range of diabetes treatment domains. The questionnaire is based on the adult version of DTSQ and adapted to pediatric type 1 diabetes. Translated to Swedish and validated in a Swedish cohort.
Measured: From baseline until 26 weeks.
Diabetes Treatment Satisfaction Questionnaire - parent report
This is a 14 item questionnaire that aim to measure parental satisfaction with the diabetes treatment. Parents are asked to rate their satisfaction on a likert scale from 0 = very unsatisfied, to 6 = very satisfied about a range of diabetes treatment domains. The questionnaire is based on the adult version of DTSQ and adapted to pediatric type 1 diabetes. Translated to Swedish and validated in a Swedish cohort.
Measured: From baseline until 15 weeks.
Diabetes Treatment Satisfaction Questionnaire - parent report
This is a 14 item questionnaire that aim to measure parental satisfaction with the diabetes treatment. Parents are asked to rate their satisfaction on a likert scale from 0 = very unsatisfied, to 6 = very satisfied about a range of diabetes treatment domains. The questionnaire is based on the adult version of DTSQ and adapted to pediatric type 1 diabetes. Translated to Swedish and validated in a Swedish cohort.
Measured: Weekly from baseline to 14 weeks
Secondary outcomes (50)
Glycaemic control
HbA1c values taken during diabetes clinic visits, registered in the national diabetes registry.
Measured: From baseline until 26 weeks.
DISABKIDS (child QoL) - parent report
This is a questionnaire that aims to measure health related quality of life in children living with chronic conditions. The parent version comprises 37 items concerning aspects of how the condition may affect the child in every-day-life, such as whether the child is worried about his/her future, if he/she spends time with friends. It is scored using five ordinal response categories ranging from "never" to "always." The negative oriented items are coded 4 ("never") to 0 ("always") whereas the positive oriented questions are inverted, so that higher score indicates higher quality of life.
Measured: From baseline until 26 weeks.
Days of physical activity
Number of day per week of physical activity. Information taken during diabetes clinic visits, and registered in the national diabetes registry.
Measured: From baseline until 26 weeks.
PedsQL - Family Impact Measure (parent QoL)
This instrument measures quality of life for parents who have children with a chronic disorder. It includes 36 items concerning physical, emotional, social and cognitive functions as well as daily activities, family relations, communication and family worry. Items are answered on a five-grade scale from 0 = never a problem, to 4 = almost always a problem. These result for each item is transformed so that 0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0, and the sum score is divided by the number of items, so that higher score indicates higher quality of life.
Measured: From baseline until 26 weeks.
Me As Parent
This is a 16-item measure that aim to measure aspects of parenting self-regulation, representing the degree to which participants perceive themselves as efficacious and competent in their role as parents. The scale includes 16 items covering the four subdomains of self-efficacy, personal agency, self-sufficiency and self-management. Items are rated on a scale from 1 = strongly disagree, to 5 = strongly agree.
Measured: From baseline until 26 weeks.
Getting Self-Management Routines Done
This 2-item questionnaire is developed by the research group and aims to serve as a parent-reported proxy for the two key self-management behaviors: taking insulin and handling high and low blood glucose values. In percentages from 0-100%, parents are asked to estimate to what extent their child 1) takes insulin and 2) handles high and low blood glucose values, in relation to all the times these behaviors are required.
Measured: From baseline until 26 weeks.
Parental Challenges in Diabetes Self-Management
This questionnaire is developed by this research group and based on common diabetes-specific themes of parental, behavioral challenges reported by parents in an interview study conducted by the group. In 12 items, parents are asked to rate how often they experience a set of challenges on a Likert scale from 0 = never, to 4 = always. These items cover four domains 1) parent worry and frustration, 2) talking, asking and reminding 3) child resistance to self-management routines, 4) child resistance to communication about self-management. This is a pilot use of the questionnaire, testing the items before deciding on future validation and psychometric evaluation. We will also use it to look at participants responses over time at a qualitative, clinical and explorative level and to investigate how the domains relate to eachother, to glycemic control and how/if responses change over time.
Measured: From baseline until 26 weeks.
General Anxiety Disorder -7
This 7-item version of the GAD questionnaire is a short measure of symptoms of anxiety. Participants are asked how often they have been bothered by a set of anxiety symptoms the last 2 weeks ranging from 0=not at all, to 7=daily. The measure will serve as a control variable in mediation analyses.
Measured: From baseline until 26 weeks.
Diabetes Family Conflict Scale - parent
This 15-item questionnaire targets family conflicts about diabetes self-management tasks. Parents are asked how often they argue with their children about a range of different self-management routines on a scale from 0=never, 1=sometimes and 2=almost always. The sum score is multiplied by 50 giving a maximum score of 100. The last update of the English version from 2023 was translated into Swedish by this research team in 2024.
Measured: From baseline until 26 weeks.
Perceived Stress Scale 10
This is the 10 item version of the standardized measurement of stress, the PSS-10. Participants are asked how often they have experienced a set of stress symptoms during the last month, ranging from 0=never to 4=very often.
Measured: From baseline until 26 weeks.
Parenting Practices Scale
Parents answer six questions about parenting practices over the last two weeks. Items are rated on a seven point Likert scale from 'Never' (coded as 1) to 'Many times a day' (coded 7), resulting in a range of 6-42 with higher scores indicating greater use of parenting skills.
Measured: From baseline until 26 weeks.
Time in Target (TiT)
TiT is the percentage of time that blood glucose levels have been within the target interval 4-8 mmol/l during the last 2 weeks.
This data will be taken from the national diabetes registry (NDR), and via the Glooko online glucose system.
Measured: From baseline until 26 weeks.
Mean glucose level
The mean glucose level during the past 2 weeks. This data will be taken from the national diabetes registry (NDR), and gathered via the Glooko online glucose system.
Measured: From baseline until 26 weeks.
Blood glucose variation
Standard deviation of blood glucose levels during the past 2 weeks. This data will be taken from the national diabetes registry (NDR), and gathered via the Glooko online glucose system.
Measured: From baseline until 26 weeks.
Time with low blood glucose
Percentage of time during the past two weeks when blood glucose values have reached below 3 mmol/l. This data will be gathered via the Glooko online glucose system.
Measured: From baseline until 26 weeks.
Ketoacidosis
Number of incidents of ketoacidosis as registered in the national diabetes registry.
Measured: From baseline until 26 weeks.
Severe hypoglycemia
Number of incidents of hypoglycemia as registered in National Diabetes Registry.
Measured: From baseline until 26 weeks.
Visits at the diabetes clinic
Number of visits registered at the National Diabetes Registry.
Measured: From baseline until 26 weeks.
Client Satisfaction Questionnaire - 8
CSQ is a cross-treatment questionnaire that aims to measure patient-reported satisfaction with the treatment they have received. This version of the CSQ includes 8 items that ask participants to rate their satisfaction on a 4-point scale where higher scores indicates higher satisfaction.
Measured: 15 weeks after baseline
DISABKIDS (child QoL) generic + diabetes module - child report
This is a 37 item questionnaire that aims to measure health related quality of life in children living with chronic conditions. Added to this questionnaire is the diabetes module with 10 diabetes-specific items. Questions concern aspects of how often the condition affects different aspects of every-day-life, such as whether the child feels lonely due to his/her condition, or if he/she is bothered by the medical treatment. It is scored using five ordinal response categories ranging from "never" to "always." The negative oriented items are coded 4 ("never") to 0 ("always") whereas the positive oriented questions are inverted, so that higher score indicates higher health related quality of life.
Measured: From baseline until 15 weeks.
Diabetes Family Conflict Scale - youth report
This 15-item questionnaire targets family conflicts about diabetes self-management tasks. Children/adolescents are asked how often they argue with their parents about a range of different self-management routines on a scale from 0=never, 1=sometimes and 2=almost always. The sum score is multiplied by 50 giving a maximum score of 100, with a higher score indicating more conflicts. The last update of the English version from 2023 was translated into Swedish by this research team in 2024.
Measured: From baseline until 15 weeks.
Time with high blood glucose
Percentage of time the past 2 weeks when blood glucose levels have reached above 13.9 mmol/l. This data will be gathered via the Glooko online glucose system.
Measured: From baseline until 15 weeks.
Glycaemic control
HbA1c values taken during diabetes clinic visits, registered in the national diabetes registry.
Measured: From baseline until 15 weeks.
Days of physical activity
Number of day per week of physical activity. Information taken during diabetes clinic visits, and registered in the national diabetes registry.
Measured: From baseline until 15 weeks.
DISABKIDS (child QoL) - parent report
This is a questionnaire that aims to measure health related quality of life in children living with chronic conditions. The parent version comprises 37 items concerning aspects of how the condition may affect the child in every-day-life, such as whether the child is worried about his/her future, if he/she spends time with friends. It is scored using five ordinal response categories ranging from "never" to "always." The negative oriented items are coded 4 ("never") to 0 ("always") whereas the positive oriented questions are inverted, so that higher score indicates higher quality of life.
Measured: From baseline until 15 weeks.
PedsQL - Family Impact Measure (parent QoL)
This instrument measures quality of life for parents who have children with a chronic disorder. It includes 36 items concerning physical, emotional, social and cognitive functions as well as daily activities, family relations, communication and family worry. Items are answered on a five-grade scale from 0 = never a problem, to 4 = almost always a problem. These result for each item is transformed so that 0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0, and the sum score is divided by the number of items, so that higher score indicates higher quality of life.
Measured: From baseline until 15 weeks.
Me As Parent
This is a 16-item measure that aim to measure aspects of parenting self-regulation, representing the degree to which participants perceive themselves as efficacious and competent in their role as parents. The scale includes 16 items covering the four subdomains of self-efficacy, personal agency, self-sufficiency and self-management. Items are rated on a scale from 1 = strongly disagree, to 5 = strongly agree.
Measured: From baseline until 15 weeks.
Getting Self-Management Routines Done
This 2-item questionnaire is developed by the research group and aims to serve as a parent-reported proxy for the two key self-management behaviors: taking insulin and handling high and low blood glucose values. In percentages from 0-100%, parents are asked to estimate to what extent their child 1) takes insulin and 2) handles high and low blood glucose values, in relation to all the times these behaviors are required.
Measured: From baseline until 15 weeks.
Parental Challenges in Diabetes Self-Management
This questionnaire is developed by this research group and based on common diabetes-specific themes of parental, behavioral challenges reported by parents in an interview study conducted by the group. In 12 items, parents are asked to rate how often they experience a set of challenges on a Likert scale from 0 = never, to 4 = always. These items cover four domains 1) parent worry and frustration, 2) talking, asking and reminding 3) child resistance to self-management routines, 4) child resistance to communication about self-management. This is a pilot use of the questionnaire, testing the items before deciding on future validation and psychometric evaluation. We will also use it to look at participants responses over time at a qualitative, clinical and explorative level and to investigate how the domains relate to eachother, to glycemic control and how/if responses change over time.
Measured: From baseline until 15 weeks.
General Anxiety Disorder -7
This 7-item version of the GAD questionnaire is a short measure of symptoms of anxiety. Participants are asked how often they have been bothered by a set of anxiety symptoms the last 2 weeks ranging from 0=not at all, to 7=daily. The measure will serve as a control variable in mediation analyses.
Measured: From baseline until 15 weeks.
Diabetes Family Conflict Scale - parent
This 15-item questionnaire targets family conflicts about diabetes self-management tasks. Parents are asked how often they argue with their children about a range of different self-management routines on a scale from 0=never, 1=sometimes and 2=almost always. The sum score is multiplied by 50 giving a maximum score of 100. The last update of the English version from 2023 was translated into Swedish by this research team in 2024.
Measured: From baseline until 15 weeks.
Perceived Stress Scale 10
This is the 10 item version of the standardized measurement of stress, the PSS-10. Participants are asked how often they have experienced a set of stress symptoms during the last month, ranging from 0=never to 4=very often.
Measured: From baseline until 15 weeks.
Time in Target (TiT)
TiT is the percentage of time that blood glucose levels have been within the target interval 4-8 mmol/l during the last 2 weeks.
This data will be taken from the national diabetes registry (NDR), and will also be gathered repeatedly during the intervention via the Glooko online glucose system.
Measured: From baseline until 15 weeks.
Visits at the diabetes clinic
Number of visits registered at the National Diabetes Registry.
Measured: From baseline until 15 weeks.
Parenting Practices Scale
Parents answer six questions about parenting practices over the last two weeks. Items are rated on a seven point Likert scale from 'Never' (coded as 1) to 'Many times a day' (coded 7), resulting in a range of 6-42 with higher scores indicating greater use of parenting skills.
Measured: From baseline until 15 weeks.
Parental Challenges in Diabetes Self-Management
This questionnaire is developed by this research group and based on common diabetes-specific themes of parental, behavioral challenges reported by parents in an interview study conducted by the group. In 12 items, parents are asked to rate how often they experience a set of challenges on a Likert scale from 0 = never, to 4 = always. These items cover four domains 1) parent worry and frustration, 2) talking, asking and reminding 3) child resistance to self-management routines, 4) child resistance to communication about self-management. This is a pilot use of the questionnaire, testing the items before deciding on future validation and psychometric evaluation. We will also use it to look at participants responses over time at a qualitative, clinical and explorative level and to investigate how the domains relate to eachother, to glycemic control and how/if responses change over time.
Measured: Weekly from baseline to 14 weeks.
Getting Self-Management Routines Done
This 2-item questionnaire is developed by the research group and aims to serve as a parent-reported proxy for the two key self-management behaviors: taking insulin and handling high and low blood glucose values. In percentages from 0-100%, parents are asked to estimate to what extent their child 1) takes insulin and 2) handles high and low blood glucose values, in relation to all the times these behaviors are required.
Measured: Weekly from baseline to 14 weeks
Mean glucose level
The mean glucose level during the past 2 weeks. This data will be taken from the national diabetes registry (NDR), and gathered via the Glooko online glucose system.
Measured: From baseline until 15 weeks.
Blood glucose variation
Standard deviation of blood glucose levels during the past 2 weeks. This data will be taken from the national diabetes registry (NDR), and via the Glooko online glucose system.
Measured: From baseline until 15 weeks.
Time with low blood glucose
Percentage of time during the past two weeks when blood glucose values have reached below 3 mmol/l. This data will be gathered via the Glooko online glucose system.
Measured: From baseline until 15 weeks.
Ketoacidosis
Number of incidents of ketoacidosis registered in the National Diabetes Registry.
Measured: From baseline until 15 weeks.
Severe hypoglycemia
Number of incidents of hypoglycemia as registered in National Diabetes Registry.
Measured: From baseline until 15 weeks.
Short Engagement Questionnaire
This questionnaire is newly developed by the research group and is to be piloted in the current study. The length of questionnaire is adapted to individual CBT treatments depending on the number of treatment components that are presented. One week after a new behavioral strategy and an associated assignment have been presented to the participants, they are asked to rate their engagement according to the following three domains:
- Frequency: how many days they have used the strategy (1 - 7),
- Intensity: how much effort they have put down in using it (0 = none, to 5 = a lot).
- Usability: how helpful they perceive the strategy to be for them (0 = not at all, to 5 = very).
The total score for each of the 3 domains are divided by the number of strategies, to reach a mean score for each of the three domains. Results will be examined at a qualitative level to guide further refinement of the intervention.
Measured: Weekly from baseline until 14 weeks.
General Anxiety Disorder -7
This 7-item version of the GAD questionnaire is a short measure of symptoms of anxiety. Participants are asked how often they have been bothered by a set of anxiety symptoms the last 2 weeks ranging from 0=not at all, to 7=daily. The measure will serve as a control variable in mediation analyses.
Measured: Weekly from baseline to 14 weeks.
Time with high blood glucose
Percentage of time the past 2 weeks when blood glucose levels have reached above 13.9 mmol/l. This data will be gathered via the Glooko online glucose system.
Measured: From baseline until 26 weeks.
Time with high blood glucose (repeated measures)
Percentage of time the past 2 weeks when blood glucose levels have reached above 13.9 mmol/l. This data will be gathered via the Glooko online glucose system.
Measured: Every second week from baseline until 14 weeks.
Blood glucose variation (repeated measures)
Standard deviation of blood glucose levels during the past 2 weeks. This data will gathered via the Glooko online glucose system.
Measured: Every second week from baseline until 14 weeks.
Mean glucose level (repeated measures)
The mean glucose level during the past 2 weeks. This data will be gathered via the Glooko online glucose system.
Measured: Every second week from baseline until 14 weeks.
Time in Target (TiT) (repeated measures)
TiT is the percentage of time that blood glucose levels have been within the target interval 4-8 mmol/l during the last 2 weeks. This data will be gathered via the Glooko online glucose system.
Measured: Every second week from baseline until 14 weeks.
Time with low blood glucose (repeated measures)
Percentage of time during the past two weeks when blood glucose values have reached below 3 mmol/l. This data will be gathered via the Glooko online glucose system.
Measured: Every second week from baseline until 14 weeks.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2024
- Study start20 Sep 2024
- Primary completion19 Aug 2025
- Study completion1 Nov 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Type 1 Diabetes MellitusStudies of the same condition, open and under way.
- More trials run by Karolinska InstitutetThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 17 participants (actual)
Sponsor and investigators
- Lead sponsor
- Karolinska Institutet
- Sponsor type
- University, hospital or other
- Collaborators
- Karolinska University Hospital
- Responsible party
- Principal investigator, Brjann Ljotsson, Karolinska Institutet
- Investigators
- Brjánn Ljótsson, Professor, Principal investigator, Karolinska Institute, Department of Clinical Neuroscience, Division of Psychology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06599840
- Sponsor's protocol ID
- Dnr2021-01558_feasibility
- Status last verified
- Aug 2025
- First submitted
- 9 Sep 2024
- Last updated
- 27 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: European GDPR regulation prevents sharing of IDP
Study at a glance
From the registry record, last updated by the sponsor on 27 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improving Self-management in Childhood Diabetes - Feasibility and Preliminary Effects of a CBT-based Intervention for Parents
- ClinicalTrials.gov ID
- NCT06599840
- Acronym / sponsor ID
- Dnr2021-01558_feasibility
- Conditions
- Type 1 Diabetes Mellitus, Parent-Child Relations, Self-management, Behavioral Intervention
- Keywords
- feasibility study, type 1 diabetes, diabetes self-management, parent support, parent intervention, pediatric self-management, behavioral intervention, pediatric type 1 diabetes
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 17 participants (actual)
- Lead sponsor
- Karolinska InstitutetUniversity, hospital or other
- Collaborators
- Karolinska University Hospital
- Study start
- 20 Sep 2024 (actual)
- Primary completion
- 19 Aug 2025 (actual)
- Study completion
- 1 Nov 2025 (estimated)
- First posted
- 19 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates feasibility and preliminary effects of a new behavioral parent intervention that aims to support and improve pediatric diabetes self-management
Detailed description
Diabetes self-management is extensive, complex and places high demands on the affected individual and his/her family. Today, half of Swedish children and adolescents with type 1 diabetes (T1D) do not reach target levels of glycemic control. Among the various factors that influence glycemic control, family function is of great importance. Parent-child conflicts surrounding self-management tasks have been shown to predict glycemic control deterioration over time. This study will explore feasibility and preliminary effects of a new behavioral parent intervention that aims to strengthen parent-child cooperation and facilitate diabetes routines in every-day-life. The results of the feasibility study will guide further refinement of the intervention, and the design of a future RCT.
Through digital ads and posters at the diabetes clinics in Stockholm, we will recruit parents of children aged 9-14 with T1D experiencing problems in getting diabetes self-management routines to work in every-day-life. The intervention is held at the hospital and includes six weekly group sessions and a booster session one month later. At the end of each session, parents plan to use a new behavioral strategy at home during the upcoming week. This feasibility study will explore participant satisfaction and attendance combined with qualitative assessments of their experiences. Preliminary effects are investigated through repeated assessments of a set of digitalized questionnaires, data from the national diabetes registry and online blood glucose data during the intervention phase, post intervention and at 3- months follow up.
This intervention is believed to be an effective way to target and prevent T1D self-management problems and may come to serve as an important complement to standard diabetes treatment.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Other | Behavioral: Parent interventionCBT-based parent intervention consisting of 7 group sessions. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (7 listed)
- Parents/guardians of children aged 9-14 with type 1 diabetes.
- The child has had type 1 diabetes for at least one year.
- The parent experience difficulties in managing daily life and/or the parent-child collaboration around self-management routines.
- The perceived difficulties should not solely be due to perceived problems in the medical aspects of the diabetes treatment, such as a perceived need for more support in insulin dosing, more diabetes education, or technical/medical support. This criterion is based solely on the subjective judgement of the parent him-/herself.
- The child receives diabetes care at one of the three diabetes clinics in the Stockholm Region.
Key exclusion criteria (3 listed)
- The parent reports current and severe psychiatric conditions in themselves or the child that need to be prioritized, such as severe depression, suicidal thoughts/self-harm, psychosis, or mania.
- The parent is involved in another psychological treatment of a behavior-changing nature that is in an active phase, either concerning themselves or a child.
- Major planned changes in diabetes treatment that require learning and behavioral changes, such as transitioning from pen to pump, and that are expected to occur during the first 3.5 months of the study (active intervention phase).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Parent interventionThis is a novel intervention based on established CBT-based parenting strategies that are regularly used to strengthen parent-child cooperation and reduce conflicts. Here, the strategies are adapted to address typical challenges of T1D family life. The program structure consists of six weekly modules and a seventh booster module. Each of the first six modules has a theme with information on a parental strategy associated with the theme, self-reflective questions, and an assignment where parents plan to implement the strategy during the upcoming week. One month later, a seventh session is held to summarize the program and make plans for future progress. | Behavioural | Intervention group |
Primary outcome
Diabetes Treatment Satisfaction Questionnaire - parent report
Time frame: From baseline until 26 weeks.
This is a 14 item questionnaire that aim to measure parental satisfaction with the diabetes treatment. Parents are asked to rate their satisfaction on a likert scale from 0 = very unsatisfied, to 6 = very satisfied about a range of diabetes treatment domains. The questionnaire is based on the adult version of DTSQ and adapted to pediatric type 1 diabetes. Translated to Swedish and validated in a Swedish cohort.
Diabetes Treatment Satisfaction Questionnaire - parent report
Time frame: From baseline until 15 weeks.
This is a 14 item questionnaire that aim to measure parental satisfaction with the diabetes treatment. Parents are asked to rate their satisfaction on a likert scale from 0 = very unsatisfied, to 6 = very satisfied about a range of diabetes treatment domains. The questionnaire is based on the adult version of DTSQ and adapted to pediatric type 1 diabetes. Translated to Swedish and validated in a Swedish cohort.
Diabetes Treatment Satisfaction Questionnaire - parent report
Time frame: Weekly from baseline to 14 weeks
This is a 14 item questionnaire that aim to measure parental satisfaction with the diabetes treatment. Parents are asked to rate their satisfaction on a likert scale from 0 = very unsatisfied, to 6 = very satisfied about a range of diabetes treatment domains. The questionnaire is based on the adult version of DTSQ and adapted to pediatric type 1 diabetes. Translated to Swedish and validated in a Swedish cohort.
50 secondary outcomes
Glycaemic control
Time frame: From baseline until 26 weeks.
DISABKIDS (child QoL) - parent report
Time frame: From baseline until 26 weeks.
Days of physical activity
Time frame: From baseline until 26 weeks.
PedsQL - Family Impact Measure (parent QoL)
Time frame: From baseline until 26 weeks.
Me As Parent
Time frame: From baseline until 26 weeks.
Getting Self-Management Routines Done
Time frame: From baseline until 26 weeks.
Parental Challenges in Diabetes Self-Management
Time frame: From baseline until 26 weeks.
General Anxiety Disorder -7
Time frame: From baseline until 26 weeks.
Diabetes Family Conflict Scale - parent
Time frame: From baseline until 26 weeks.
Perceived Stress Scale 10
Time frame: From baseline until 26 weeks.
Parenting Practices Scale
Time frame: From baseline until 26 weeks.
Time in Target (TiT)
Time frame: From baseline until 26 weeks.
Mean glucose level
Time frame: From baseline until 26 weeks.
Blood glucose variation
Time frame: From baseline until 26 weeks.
Time with low blood glucose
Time frame: From baseline until 26 weeks.
Ketoacidosis
Time frame: From baseline until 26 weeks.
Severe hypoglycemia
Time frame: From baseline until 26 weeks.
Visits at the diabetes clinic
Time frame: From baseline until 26 weeks.
Client Satisfaction Questionnaire - 8
Time frame: 15 weeks after baseline
DISABKIDS (child QoL) generic + diabetes module - child report
Time frame: From baseline until 15 weeks.
Diabetes Family Conflict Scale - youth report
Time frame: From baseline until 15 weeks.
Time with high blood glucose
Time frame: From baseline until 15 weeks.
Glycaemic control
Time frame: From baseline until 15 weeks.
Days of physical activity
Time frame: From baseline until 15 weeks.
DISABKIDS (child QoL) - parent report
Time frame: From baseline until 15 weeks.
PedsQL - Family Impact Measure (parent QoL)
Time frame: From baseline until 15 weeks.
Me As Parent
Time frame: From baseline until 15 weeks.
Getting Self-Management Routines Done
Time frame: From baseline until 15 weeks.
Parental Challenges in Diabetes Self-Management
Time frame: From baseline until 15 weeks.
General Anxiety Disorder -7
Time frame: From baseline until 15 weeks.
Diabetes Family Conflict Scale - parent
Time frame: From baseline until 15 weeks.
Perceived Stress Scale 10
Time frame: From baseline until 15 weeks.
Time in Target (TiT)
Time frame: From baseline until 15 weeks.
Visits at the diabetes clinic
Time frame: From baseline until 15 weeks.
Parenting Practices Scale
Time frame: From baseline until 15 weeks.
Parental Challenges in Diabetes Self-Management
Time frame: Weekly from baseline to 14 weeks.
Getting Self-Management Routines Done
Time frame: Weekly from baseline to 14 weeks
Mean glucose level
Time frame: From baseline until 15 weeks.
Blood glucose variation
Time frame: From baseline until 15 weeks.
Time with low blood glucose
Time frame: From baseline until 15 weeks.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Aug 2025.
- Individual participant dataSharing planned: No. European GDPR regulation prevents sharing of IDP
Related trials for Type 1 Diabetes Mellitus
Active, not recruitingPhase 3
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
Type 1 Diabetes
RecruitingObservational study
Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy
Type 1 Diabetes
Active, not recruitingPhase 1/2
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Obesity
RecruitingPhase 3
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Not yet recruitingPhase 1/2
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Sarcoma, Osteoid Sarcoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Brjánn Ljótsson, Professor principal investigator
Karolinska Institute, Department of Clinical Neuroscience, Division of Psychology
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Parent intervention in people with Type 1 Diabetes Mellitus and Parent-Child Relations, run by Karolinska Institutet at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 27 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Diabetes Treatment Satisfaction Questionnaire - parent report (time frame: From baseline until 26 weeks.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2025.